Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer.

Emily van SeventerJ Peter MarquardtAmelie S Troschel Till Dominik BestNora HorickChinenye C Azoba Richard A NewcombEric J RoelandMichael H Rosenthal Christopher P BridgeJoseph A GreerAreej El-JawahriJennifer TemelFlorian J FintelmannRyan D Nipp

Published in: Journal of the National Comprehensive Cancer Network : JNCCN (2021)

Although muscle mass (quantity) only correlated with survival, we found that muscle radiodensity (quality) was associated with patients' symptoms, healthcare use, and survival. These findings underscore the added importance of assessing muscle quality when seeking to address adverse muscle changes in oncology.

Keyphrases

skeletal muscle
palliative care
advanced cancer
healthcare
end stage renal disease
newly diagnosed
insulin resistance
chronic kidney disease
ejection fraction
prognostic factors
free survival
metabolic syndrome
emergency department
type diabetes
patient reported
risk factors
adipose tissue
patient reported outcomes